(责任编辑：宋政 HN002) 格隆汇8月1日｜A股市场中药股逆势上涨，其中，生物谷涨近25%，维康药业20CM涨停，新光药业 (300519)涨13%，大唐药业涨近11%，天目药业(600671)、新天药业(002873)、太龙药业(600222)、奇正 藏药(002287)、贵州百灵(002424)10CM涨停，众生药业(002317)涨超8%，亚宝药业(600351)、沃华医药 (002107)涨超6%。 | 代码 | 名称 | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | | 833266 | 生物谷 | 24.91 | 17.60亿 | 51.12 | | 300878 | 维康药业 | 20.00 | 37.10亿 | 71.51 | | 300519 | 新光药业 | 13.04 | 31.76亿 | 52.71 | | 836433 | 大唐药业 | 10.76 | 22.14亿 | 42.65 | | 600671 | 天目药业 | 10.03 | 18.71亿 | 74.94 | | 002873 | 新天药业 | 10. ...

MACD金叉信号形成，这些股涨势不错！ 格隆汇8月1日｜A股市场中药股逆势上涨，其中，生物谷（维权）涨近25%，维康药业（维权）20CM 涨停，新光药业涨13%，大唐药业涨近11%，天目药业、新天药业、太龙药业、奇正藏药、贵州百灵 （维权）10CM涨停，众生药业涨超8%，亚宝药业、沃华医药（维权）涨超6%。 | 代码 | 名称 | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | | 833266 | 生物谷 | 24.91 | 17.60亿 | 51.12 | | 300878 | 维康药业 | 20.00 | 37.10亿 | 71.51 | | 300519 | 新光药业 | 13.04 | 31.76 乙 | 52.71 | | 836433 | 大唐药业 | 10.76 | 22.14亿 | 42.65 | | 600671 | 天目药业 | 10.03 | 18.71亿 | 74.94 | | 002873 | 新天药业 | 10.03 | 29.19亿 | 27.68 | | 600222 | 太龙药业 | 10.00 | 39.14 ...

（文章来源：每日经济新闻） 每经AI快讯，8月1日，午后中药板块持续逆势拉升，天目药业、华森制药涨停，生物谷一度触及30%涨 停，新光药业、大唐药业涨超10%，亚宝药业、沃华医药、陇神戎发、粤万年青等跟涨。 ...

Group 1 - The A-share traditional Chinese medicine sector is experiencing a significant upward trend, with companies like Tianmu Pharmaceutical and Huasen Pharmaceutical hitting the daily limit increase [1] - Biotech Valley reached a peak of 30cm limit increase, indicating strong market interest and investor confidence [1] - Other companies such as New Light Pharmaceutical and Datang Pharmaceutical saw increases of over 10%, reflecting a broader positive movement in the sector [1] Group 2 - Additional companies including Yabao Pharmaceutical, Wohua Pharmaceutical, Longshen Rongfa, and Guangdong Wannianqing also showed gains, contributing to the overall bullish sentiment in the traditional Chinese medicine market [1]

Core Viewpoint - The A-share assisted reproductive sector is experiencing significant growth, with multiple companies reaching new highs and notable stock price increases [1] Company Performance - Fuyuan Pharmaceutical reached an all-time high during trading [1] - Gongtong Pharmaceutical, Hanshang Group, and Lide Man all hit the daily limit up [1] - Anke Bio increased by over 15% [1] - Guangshengtang rose by over 10% [1] - Other companies such as Xinguang Pharmaceutical, Dajia Weikang, BeiYinMei, Xinghao Pharmaceutical, and Beirui Gene also saw price increases [1]

证券代码：300519 证券简称：新光药业 公告编号：2025-018 浙江新光药业股份有限公司 关于注销部分募集资金专户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江新光药业股份有限公司（以下简称"公司"）于 2025 年 4 月 17 日召 开第五届董事会第三次会议及第五届监事会第三次会议，审议通过《关于首次公 开发行股票的部分募集资金投资项目结项并将节余募集资金永久补充流动资金及 注销部分募集资金专用账户的议案》，并于 2025 年 5 月 13 日召开的 2024 年度 股东大会审议通过了上述议案，同意公司将由公司全资子公司浙江新光医药科技 有限公司（以下简称"新光医药科技"）建设的"现代中药研发中心建设项目" 进行结项，将节余募集资金永久补充流动资金，并对相关募集资金专户进行销户 处理。具体详见公司于 2025 年 4 月 21 日在巨潮资讯网（www.cninfo.com.cn） 披露的《关于首次公开发行股票的部分募集资金投资项目结项并将节余募集资金 永久补充流动资金及注销部分募集资金专用账户的公告》（公告编号：2025- 010）。 ...

Group 1 - Ningde Times participated in the completion of the Zeyuan Fund, with a total scale of 10.128 billion yuan, increasing by 50.42% from the previous announcement [3] - Zhongjin Gold's controlling shareholder plans to inject four companies into the company to resolve competition issues, including acquiring stakes in Inner Mongolia Jintao and others [4][5] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [6] Group 2 - China Shenhua intends to acquire 7.43% of the National Energy Group Financial Company for 2.929 billion yuan, which is expected to increase its net profit by 97 million yuan [7] - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange [8] - Hualan Shares is establishing a joint venture for Tibetan medicinal baths and plaster products, with a registered capital of 7 million yuan [15] Group 3 - Yunnan Copper plans to acquire 40% of Liangshan Mining through a share issuance, with the stock resuming trading on May 26 [10] - Ruishun Technology's subsidiary plans to establish a joint venture in Malaysia to provide automation solutions [11] - ST Quanwei's stock will be subject to additional risk warnings due to ongoing litigation involving a subsidiary [12] Group 4 - Hengfeng Information's controlling shareholder has terminated the agreement to transfer part of the company's shares, with no impact on control [13] - Huadian Technology's subsidiary has not yet commenced substantial construction on a polyurethane new materials project [14] - ST Yinjian will remove the delisting risk warning and some other risk warnings, changing its stock name [38] Group 5 - China Tonghao won approximately 3.789 billion yuan in contracts in the rail transit market from March to April [39] - Intercontinental Oil and Gas plans to invest about 848 million USD in the Iraq South Basra project [40][41] - Jiaying Pharmaceutical's subsidiary signed a contract for the development of a traditional Chinese medicine innovation project [42] Group 6 - Ruidong Intelligent signed a strategic cooperation agreement with Shunde Vocational and Technical College to enhance collaboration in technology [43] - Jiaojian Co. won a bid for a drainage project worth 225 million yuan [44] - Hengshun Vinegar's controlling shareholder plans to increase its stake in the company by 50 to 100 million yuan [45]

Mergers and Acquisitions - Zhongjin Gold plans to acquire 49.34% stake in Inner Mongolia Jintao and 80% stake in Hebei Dabaiyang Gold Mine, along with 70% stakes in Liaoning Tianli and Liaoning Jinfeng Gold Mining, to resolve industry competition issues [1] - Dike Co. intends to acquire 60% stake in Zhejiang Sote for 696 million yuan, gaining control over the Solamet photovoltaic silver paste business [2] - China Shenhua plans to acquire 7.43% stake in its financial subsidiary for 2.929 billion yuan, changing the ownership structure to 60% for State Energy Investment Group and 40% for China Shenhua [3] Shareholding Changes - New Light Pharmaceutical's major shareholder plans to reduce its stake by up to 3%, equating to a maximum of 4.8 million shares [4] - Xingfa Group's supervisor increased his shareholding by 15,000 shares, amounting to 311,500 yuan, representing 0.0014% of the total shares [5] - Changhua Group's shareholders plan to reduce their holdings by up to 3%, totaling a maximum of 14.1 million shares [6] Risk Matters - ST Quanwei's stock will face additional risk warnings due to a lawsuit involving a guarantee amounting to 10.0126 million yuan, which exceeds 5% of the company's latest audited net assets [7] - Jinhua Co.'s chairman is under investigation for alleged violations related to shareholding disclosure, but this will not affect the company's daily operations [8]

Company Announcements - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange to accelerate international strategy and enhance overseas financing capabilities [1] - Zhongjin Gold's controlling shareholder plans to inject four companies, including Inner Mongolia Jintao, into the company to resolve competition issues [2] - Hanchuan Intelligent has filed a lawsuit against CATL and its subsidiaries for approximately 60.88 million yuan due to payment defaults [2] - Yunnan Copper intends to acquire a 40% stake in Liangshan Mining, with stock resuming trading on May 26 [3] - China Shenhua plans to acquire a 7.43% stake in China Energy Group Financial Company for 2.929 billion yuan [3] - Dike Co. intends to acquire 60% of Zhejiang Suote for 696 million yuan to control the Solamet photovoltaic silver paste business [4] - Jin Hua Co.'s chairman is under investigation for information disclosure violations, but it will not affect the company's operations [4] Financing and Investments - Heng Rui Pharmaceutical's H-shares will be listed on May 23, 2025, with a total issuance of 225 million shares at a price of 44.05 HKD per share [23] - Ningde Times' investment fund has increased to 10.128 billion yuan, with the company's stake reduced to 6.91% [8] - Intercontinental Oil and Gas expects to invest approximately 848 million USD in the Iraq South Basra project [9] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [10] Project Bids and Contracts - China Communications has won important rail transit projects totaling approximately 3.789 billion yuan [22] - Anhui Construction has received multiple project bids totaling over 2 billion yuan [22] Operational Updates - Zijin Mining's Kamoa-Kakula copper mine has suspended some underground mining operations due to seismic activity, potentially impacting future production [21] - Shaanxi Natural Gas will reduce pipeline transportation prices by 0.0386 yuan per cubic meter, expected to decrease net profit by approximately 222 million yuan in 2025 [20]

Group 1 - The core point of the announcement is that a major shareholder, Hongfeng Investment, plans to reduce its stake in XinGuang Pharmaceutical by up to 4.8 million shares, which represents a maximum of 3% of the company's total share capital [1] - The reduction will occur within three months starting from 15 trading days after the announcement, utilizing both centralized bidding and block trading methods [1] - Specifically, the shareholder intends to sell up to 1.6 million shares (1% of total share capital) through centralized bidding and up to 3.2 million shares (2% of total share capital) via block trading [1]